NCT00779233View on ClinicalTrials.gov

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Zidovudine tablets 300 mg

Trial Locations (1)

89121

Novum Pharmaceutical Research Services, Las Vegas

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00779233 - Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions | Biotech Hunter | Biotech Hunter